| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/26/2007 | US7235579 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 06/26/2007 | US7235575 Guanidine mimics as factor Xa inhibitors |
| 06/26/2007 | US7235574 Pentafluorosulfanyl compounds |
| 06/26/2007 | US7235571 Insecticides; for human or veterinary medicine |
| 06/26/2007 | US7235570 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 06/26/2007 | US7235567 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235559 Therapeutic quinazoline derivatives |
| 06/26/2007 | US7235546 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 06/26/2007 | US7235545 (Calcitonin gene related peptide); azepinone ligands; migranes; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 06/26/2007 | US7235541 Neurokinin antagonists for use as medicaments |
| 06/26/2007 | US7235537 Antiproliferative agents; anticancer agents; antiinflammatory agents |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/21/2007 | WO2007070892A2 Useful indole compounds |
| 06/21/2007 | WO2007070826A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/21/2007 | WO2007070606A2 Isoxazolines for controlling invertebrate pests |
| 06/21/2007 | WO2007070398A1 Polycyclic indazole derivatives that are erk inhibitors |
| 06/21/2007 | WO2007069771A1 Benzoylpyrazole compounds and herbicides containing them |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007068814A1 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof |
| 06/21/2007 | WO2007068621A1 Novel fused pyrrole derivatives |
| 06/21/2007 | WO2007048841A3 Novel indole-containing beta agonists, method for producing them and their use as drugs |
| 06/21/2007 | WO2007042544A3 Imidazole derivatives and their use for modulating the gabaa receptor complex |
| 06/21/2007 | WO2007003604A3 Hists1mine h3 receptor antagonists |
| 06/21/2007 | WO2006123257A8 Phenyl-3-{(3-(1h-pyrrol-2-yl)-[1, 2 , 4]0xadiaz0l-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 06/21/2007 | US20070142634 phenylamide and pyridylamide derivative compounds having a terminal or branched amino or hydroxyl group |
| 06/21/2007 | US20070142446 (Indol-3-yl) heterocycle derivatives as a agonists of the cannabinoid cb1 receptor |
| 06/21/2007 | US20070142438 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia |
| 06/21/2007 | US20070142437 Chemical compounds |
| 06/21/2007 | US20070142430 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 06/21/2007 | US20070142413 Pyrazole derivatives as inhibitors of receptor tyrosone kinases |
| 06/21/2007 | US20070142409 3-Substituted-4-pyrimidone derivatives |
| 06/21/2007 | US20070142397 Phenypiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 06/21/2007 | US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/21/2007 | US20070142390 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors |
| 06/21/2007 | US20070142380 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 06/21/2007 | US20070142377 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives |
| 06/21/2007 | US20070142375 Pyrrolidine derivatives as factor xa inhibitors |
| 06/21/2007 | US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 06/21/2007 | US20070142373 Quinoline derivatives as phosphodiesterase inhibitors |
| 06/21/2007 | US20070142372 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/21/2007 | US20070142371 Anti-Cytokine Heterocyclic Compounds |
| 06/21/2007 | US20070142368 N4-(2-methoxyethyl)-N6-(5methyl-1H-pyrazol-3-yl)-2-styrylpyrimidine-4,6-diamine; Aurora protein kinase inhibitors; anticarcinogenic agents; antitumor agents; antimetastatic agents; melanoma, lymphoma, leukemia; cancer of the colon, colorectum, breast, lung, kidney, pancreas, kidney, stomach; ovaries |
| 06/21/2007 | US20070142365 HIV integrase inhibitors such as 5-(1,1-Dioxido-1,2-thiazinan-2-yl)-7[5-(4-fluorobenzyl)-1,3,4-oxadiazol-2-yl]-1,6-naphthyridin-8-ol, useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC |
| 06/21/2007 | US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/21/2007 | US20070142350 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates |
| 06/21/2007 | US20070142349 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof |
| 06/21/2007 | US20070142333 Cycloalkyl inhibitors of potassium channel function |
| 06/21/2007 | US20070142305 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; platelet-derived growth factor receptor (PDGF-R) |
| 06/21/2007 | US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide |
| 06/21/2007 | US20070142245 E.g., bis(1,2,3,4-tetrahydroquinolin-8-yl)amine, bis(2,3-dihydro-1-benzofuran-5-yl)amine and bis(1,3-benzodioxol-5-yl)amine; oil soluble and serve as antioxidants, antiozoants, heat stabilizers and ultraviolet light stabilizers |
| 06/21/2007 | US20070141659 Sets and Compositions Pertaining to Analyte Determination |
| 06/21/2007 | US20070140962 Light Sensitive Compounds for Instant Determination of Organ Function |
| 06/21/2007 | US20070140960 Methods for imaging soluble a-beta |
| 06/21/2007 | CA2637740A1 Fused pyrrole derivatives |
| 06/21/2007 | CA2634168A1 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 06/21/2007 | CA2633569A1 N-(5-membered heteroaromatic ring)-amido anti-viral compounds |
| 06/21/2007 | CA2633541A1 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 06/21/2007 | CA2633252A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/21/2007 | CA2633023A1 Polycyclic indazole derivatives that are erk inhibitors |
| 06/21/2007 | CA2632030A1 Compounds which modulate the cb2 receptor |
| 06/20/2007 | EP1798230A1 Substituted alkylamine derivatives and methods of use |
| 06/20/2007 | EP1798223A2 Aryl sulfonamides |
| 06/20/2007 | EP1797087A1 Carbo- and hetero-cyclic antibiotics and use thereof |
| 06/20/2007 | EP1797086A1 Indole derivatives, their manufacture and use as pharmaceutical agents |
| 06/20/2007 | EP1797084A1 NOVEL HETEROCYCLIC NF-kB INHIBITORS |
| 06/20/2007 | EP1797081A1 Benzoxazine compounds derivated from phenolphthalein having flame-retardant properties and a process for their preparation |
| 06/20/2007 | EP1797080A1 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
| 06/20/2007 | EP1797079A1 Proline derivatives |
| 06/20/2007 | EP1797076A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/20/2007 | EP1797074A1 Compounds, compositions containing them, preparation thereof and uses thereof iiii |
| 06/20/2007 | EP1797071A1 Carbonyl compounds usable as coagulation factor xa inhibitors |
| 06/20/2007 | EP1797070A1 Compounds, compositions containing them, preparations thereof and uses thereof ii |
| 06/20/2007 | EP1797069A2 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 06/20/2007 | EP1797065A2 Acyclic 1,3-diamines and uses therefor |
| 06/20/2007 | EP1797062A1 Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors |
| 06/20/2007 | EP1797051A1 Benzoxazine and quinoxaline derivatives and uses |
| 06/20/2007 | EP1797048A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 06/20/2007 | EP1797045A1 Novel pyrimidine derivatives and their use as ppar-alpha modulators |
| 06/20/2007 | EP1797042A1 Indozolone derivatives as 11b-hsd1 inhibitors |
| 06/20/2007 | EP1796665A2 Compounds for the treatment of dyslipidemia and other lipid disorders |
| 06/20/2007 | EP1663966B1 1,3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 06/20/2007 | EP1599452B1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis |
| 06/20/2007 | EP1487824B1 Diamino-pyrimidines and their use as angiogenesis inhibitors |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | CN1984907A Novel heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 06/20/2007 | CN1984906A Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity |
| 06/20/2007 | CN1984901A Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors. |
| 06/20/2007 | CN1984900A Indole derivatives having piperidine rings |
| 06/20/2007 | CN1984894A Compounds and compositions as PPAR modulators |
| 06/20/2007 | CN1984892A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/20/2007 | CN1984662A Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/20/2007 | CN1984655A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/20/2007 | CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 06/20/2007 | CN1982308A Substituted pyrazoles |
| 06/20/2007 | CN1982306A Alpha-substituted-2-methyl-5-nitro-diazole-1-alcohol derivative with optical activity |
| 06/20/2007 | CN1321996C Process for preparing 2-iminopyrrolidine derivatives |
| 06/19/2007 | US7232909 Pyridine derivatives |
| 06/19/2007 | US7232836 1-(3-halopyrid-2-yl)-3-substituted-5-((2,4-substituted-6-aminocarbonyl)phenylaminocarbonyl) pyrazoles insecticides |